MedPath

Effectiveness of the Treatment With Budesonide Nebuliser among Patients with Acute Asthma

Phase 3
Recruiting
Conditions
Asthma.
Mild intermittent asthma with (acute) exacerbation
J45.21
Registration Number
IRCT20170531034256N2
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

Definitive diagnosis of asthma
being older than 18

Exclusion Criteria

the Flu
Patients who are treated with other forms of medication
Pregnant patients
obvious infection in Chest X-ray
Patient with heart , kidney, liver disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Peak expiratory flow. Timepoint: 0 min, 30 min, 60 min, 90 min. Method of measurement: Peak Flow Meter.;Hospitalization duration. Timepoint: final. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath